Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiannan Feng

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
The International Journal of Biochemistry & Cell Biology|April 21, 2007
Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular designMing Lv, Yan Li, Ming Yu, et al.
Oncology Letters|June 13, 2019
Engineered AXL<sup>-ECD</sup>-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migrationYanting Duan, Bo Hu, Chunxia Qiao, et al.
Oncology Letters|June 25, 2026
Erratum: [Corrigendum] Engineered AXL<sup>-ECD</sup>-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migrationYanting Duan, Bo Hu, Chunxia Qiao, et al.
Frontiers in Bioengineering and Biotechnology|June 1, 2022
CAD v1.0: Cancer Antigens Database Platform for Cancer Antigen Algorithm Development and Information ExplorationJijun Yu, Luoxuan Wang, Xiangya Kong, et al.
Journal of Biomolecular Screening|February 6, 2014
A Single-Chain Antibody Using LoxP511 as the Linker Enables Large-Content Phage Library Construction via Cre/LoxP RecombinationYan Zhang, Wei Wang, Ming Lv, et al.
Journal of Ovarian Research|November 27, 2014
Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3Wei Wang, Yan Zhang, Ming Lv, et al.
Immunology|October 15, 2009
Interleukin-17-producing gammadelta+ T cells protect NOD mice from type 1 diabetes through a mechanism involving transforming growth factor-betaGencheng Han, Renxi Wang, Guojiang Chen, et al.
BMC Biotechnology|March 1, 2014
Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularizationQun Wang, Jing Yang, Kun Tang, et al.
Toxins|August 27, 2025
A Novel Anti-BoNT/A Neutralizing Antibody Possessed Overlapped Epitope with SV2 and Had Prolonged Half-Life In VivoShangde Peng, Naijing Hu, Fenghao Peng, et al.
Journal of Pharmaceutical Sciences|March 31, 2015
Improving Trastuzumab's Stability Profile by Removing the Two Degradation HotspotsYuemei Yang, Jian Zhao, Shusheng Geng, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
The International Journal of Biochemistry & Cell Biology|April 21, 2007
Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular designMing Lv, Yan Li, Ming Yu, et al.
Oncology Letters|June 13, 2019
Engineered AXL<sup>-ECD</sup>-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migrationYanting Duan, Bo Hu, Chunxia Qiao, et al.
Oncology Letters|June 25, 2026
Erratum: [Corrigendum] Engineered AXL<sup>-ECD</sup>-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migrationYanting Duan, Bo Hu, Chunxia Qiao, et al.
Frontiers in Bioengineering and Biotechnology|June 1, 2022
CAD v1.0: Cancer Antigens Database Platform for Cancer Antigen Algorithm Development and Information ExplorationJijun Yu, Luoxuan Wang, Xiangya Kong, et al.
Journal of Biomolecular Screening|February 6, 2014
A Single-Chain Antibody Using LoxP511 as the Linker Enables Large-Content Phage Library Construction via Cre/LoxP RecombinationYan Zhang, Wei Wang, Ming Lv, et al.
Journal of Ovarian Research|November 27, 2014
Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3Wei Wang, Yan Zhang, Ming Lv, et al.
Immunology|October 15, 2009
Interleukin-17-producing gammadelta+ T cells protect NOD mice from type 1 diabetes through a mechanism involving transforming growth factor-betaGencheng Han, Renxi Wang, Guojiang Chen, et al.
BMC Biotechnology|March 1, 2014
Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularizationQun Wang, Jing Yang, Kun Tang, et al.
Toxins|August 27, 2025
A Novel Anti-BoNT/A Neutralizing Antibody Possessed Overlapped Epitope with SV2 and Had Prolonged Half-Life In VivoShangde Peng, Naijing Hu, Fenghao Peng, et al.
Journal of Pharmaceutical Sciences|March 31, 2015
Improving Trastuzumab's Stability Profile by Removing the Two Degradation HotspotsYuemei Yang, Jian Zhao, Shusheng Geng, et al.
Pageof 16